Vcanbio Cell & Gene Engineering Corp., Ltd Share Price
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.65 CNY | +0.77% |
|
+0.88% | +13.69% |
| Capitalization | 11.49B 1.69B 1.43B 1.32B 1.24B 2.31B 157B 2.35B 15.45B 6.05B 75.53B 6.32B 6.19B 268B | P/E ratio 2023 |
88.1x | P/E ratio 2024 | 87.7x |
|---|---|---|---|---|---|
| Enterprise value | 10.09B 1.48B 1.25B 1.16B 1.09B 2.03B 138B 2.07B 13.57B 5.31B 66.32B 5.55B 5.43B 235B | EV / Sales 2023 |
5.05x | EV / Sales 2024 | 4.67x |
| Free-Float |
72.94% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +0.77% | ||
| 1 week | +0.88% | ||
| Current month | -7.28% | ||
| 1 month | -3.18% | ||
| 3 months | +4.11% | ||
| 6 months | +15.99% | ||
| Current year | +13.69% |
| 1 week | 27.87 |  | 29.59 |
| 1 month | 27.58 | | 32.99 |
| Current year | 24.85 | | 32.99 |
| 1 year | 20.89 | | 32.99 |
| 3 years | 12.88 | | 32.99 |
| 5 years | 12.88 | | 32.99 |
| 10 years | 12.88 | | 42.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Qi Wang
CEO | Chief Executive Officer | 61 | 14/01/2024 |
Hai Bin Li
PRN | Corporate Officer/Principal | 55 | 31/01/2016 |
Xu Li
PRN | Corporate Officer/Principal | 41 | 15/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Jia Gong
CHM | Chairman | 61 | 25/03/2022 |
Yong Wang
BRD | Director/Board Member | 59 | 06/02/2014 |
Xin Yi Hou
BRD | Director/Board Member | 66 | 18/05/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.77% | +0.88% | +31.78% | +44.11% | 1.9B | |
| +0.49% | +0.77% | -19.76% | -4.97% | 12.77B | |
| -1.78% | -9.05% | +87.91% | +246.37% | 11.33B | |
| +3.76% | +11.73% | - | - | 5.71B | |
| +1.45% | +7.51% | -17.81% | -5.33% | 5.38B | |
| -2.85% | -8.79% | +105.55% | +65.67% | 4.79B | |
| -1.35% | -1.54% | -12.87% | -22.63% | 5.37B | |
| +0.38% | +6.60% | -34.12% | -34.96% | 3.94B | |
| +2.22% | +16.18% | +206.34% | -53.08% | 3.17B | |
| +0.73% | -0.52% | -17.93% | -43.42% | 2.86B | |
| Average | +0.38% | +1.19% | +36.57% | +21.31% | 5.72B | |
| Weighted average by Cap. | +0.11% | -0.14% | +31.31% | +49.43% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 1.59B 233M 198M 182M 172M 320M 21.76B 326M 2.14B 837M 10.45B 875M 856M 37.07B | 1.59B 233M 197M 182M 171M 319M 21.71B 325M 2.13B 834M 10.42B 872M 854M 36.97B |
| Net income | 106M 15.61M 13.24M 12.22M 11.51M 21.45M 1.46B 21.8M 143M 56.03M 700M 58.58M 57.35M 2.48B | 100M 14.72M 12.48M 11.52M 10.85M 20.22M 1.37B 20.55M 135M 52.82M 660M 55.22M 54.07M 2.34B |
| Net Debt | -1.45B -213M -181M -167M -157M -293M -19.9B -298M -1.96B -765M -9.56B -800M -783M -33.9B | -1.4B -206M -174M -161M -152M -282M -19.18B -287M -1.88B -738M -9.21B -771M -755M -32.67B |
Employees
2,014
Calendar
04-25 -
Earnings release - Annual 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/04/26 | 28.65 ¥ | +0.77% | 11,681,910 |
| 14/04/26 | 28.43 ¥ | +0.82% | 9,858,393 |
| 13/04/26 | 28.20 ¥ | -2.12% | 10,320,830 |
| 10/04/26 | 28.81 ¥ | +1.09% | 13,276,700 |
| 09/04/26 | 28.50 ¥ | -1.32% | 11,682,190 |
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600645 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition